Interaction Between BEND5 and RBPJ Suppresses Breast Cancer Growth and Metastasis Via Inhibiting Notch Signaling

Overview

Journal Int J Biol Sci

Specialty Biology

Date 2022 Jul 18

PMID 35844785

Authors

Yanzhu Shi

Deyu Zhang

Jingyi Chen

Qiwei Jiang

Songze Song

Yue Mi

Tao Wang

Qinong Ye

Affiliations

Soon will be listed here.

Abstract

High frequent metastasis is the major cause of breast cancer (BC) mortality among women. However, the molecular mechanisms underlying BC metastasis remain largely unknown. Here, we identified six hub BC metastasis driver genes (BEND5, HSD11B1, NEDD9, SAA2, SH2D2A and TNFSF4) through bioinformatics analysis, among which BEND5 is the most significant gene. Low BEND5 expression predicted advanced stage and shorter overall survival in BC patients. Functional experiments showed that BEND5 could suppress BC growth and metastasis and . Mechanistically, BEND5 inhibits Notch signaling via directly interacting with transcription factor RBPJ/CSL. BEN domain of BEND5 interacts with the N-terminal domain (NTD) domain of RBPJ, thus preventing mastermind like transcriptional coactivator (MAML) from forming a transcription activation complex with RBPJ. Our study provides a novel insight into regulatory mechanisms underlying Notch signaling and suggests that BEND5 may become a promising target for BC therapy.

Citing Articles

Clofazimine enhances anti-PD-1 immunotherapy in glioblastoma by inhibiting Wnt6 signaling and modulating the tumor immune microenvironment.

Zhao Y, Song Y, Li W, Wu J, Zhao Z, Qu T Cancer Immunol Immunother. 2025; 74(4):137.

PMID: 40053076 PMC: 11889303. DOI: 10.1007/s00262-025-03994-5.

Heterogeneity analysis and prognostic model construction of HPV negative oral squamous cell carcinoma T cells using ScRNA-seq and bulk-RNA analysis.

Li C, Lv Z, Li C, Yang S, Liu F, Zhang T Funct Integr Genomics. 2025; 25(1):25.

PMID: 39849233 PMC: 11759468. DOI: 10.1007/s10142-024-01525-6.

The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis.

Lei Z, Teng Q, Koya J, Liu Y, Chen Z, Zeng L Front Immunol. 2024; 15:1417201.

PMID: 39403386 PMC: 11471544. DOI: 10.3389/fimmu.2024.1417201.

Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancer.

Yao Y, Lv H, Zhang M, Li Y, Herman J, Brock M Front Med. 2024; 18(4):721-734.

PMID: 38926248 DOI: 10.1007/s11684-023-1053-3.

A novel CD8 T cell-related gene signature for predicting the prognosis and immunotherapy efficacy in bladder cancer.

Lin F, Ke Z, Xue Y, Chen J, Cai H, Lin Y Inflamm Res. 2023; 72(8):1665-1687.

PMID: 37578544 DOI: 10.1007/s00011-023-01772-6.

References

Antila C, Rraklli V, Blomster H, Dahlstrom K, Salminen T, Holmberg J . Sumoylation of Notch1 represses its target gene expression during cell stress. Cell Death Differ. 2018; 25(3):600-615. PMC: 5864205. DOI: 10.1038/s41418-017-0002-6. View

Dai Q, Andreu-Agullo C, Insolera R, Wong L, Shi S, Lai E . BEND6 is a nuclear antagonist of Notch signaling during self-renewal of neural stem cells. Development. 2013; 140(9):1892-902. PMC: 3631965. DOI: 10.1242/dev.087502. View

Sung H, Ahn J, Yoon Y, Rhim T, Park C, Park J . Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer. J Proteome Res. 2010; 10(3):1383-95. DOI: 10.1021/pr101154j. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Xu Z, Wang Z, Jia X, Wang L, Chen Z, Wang S . MMGZ01, an anti-DLL4 monoclonal antibody, promotes nonfunctional vessels and inhibits breast tumor growth. Cancer Lett. 2016; 372(1):118-27. DOI: 10.1016/j.canlet.2015.12.025. View

Kumar S, Srivastav R, Wilkes D, Ross T, Kim S, Kowalski J . Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer. Oncogene. 2018; 38(12):2092-2107. PMC: 6756232. DOI: 10.1038/s41388-018-0562-z. View

Zhang F, Han B, Xu R, Zhu Q, Wu Q, Wei H . Identification of plasma SAA2 as a candidate biomarker for the detection and surveillance of non-small cell lung cancer. Neoplasma. 2021; 68(6):1301-1309. DOI: 10.4149/neo_2021_210228N263. View

Yan Z, Sheng Z, Zheng Y, Feng R, Xiao Q, Shi L . Cancer-associated fibroblast-derived exosomal miR-18b promotes breast cancer invasion and metastasis by regulating TCEAL7. Cell Death Dis. 2021; 12(12):1120. PMC: 8636636. DOI: 10.1038/s41419-021-04409-w. View

Jubb A, Soilleux E, Turley H, Steers G, Parker A, Low I . Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer. Am J Pathol. 2010; 176(4):2019-28. PMC: 2843489. DOI: 10.2353/ajpath.2010.090908. View

10.

Pitchai G, Kaulich M, Bizard A, Mesa P, Yao Q, Sarlos K . A novel TPR-BEN domain interaction mediates PICH-BEND3 association. Nucleic Acids Res. 2017; 45(19):11413-11424. PMC: 5737856. DOI: 10.1093/nar/gkx792. View

11.

Feigelson H, Teras L, Diver W, Tang W, Patel A, Stevens V . Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II. Breast Cancer Res. 2008; 10(4):R57. PMC: 2575528. DOI: 10.1186/bcr2114. View

12.

Sun Z, Li X, Massena S, Kutschera S, Padhan N, Gualandi L . VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. J Exp Med. 2012; 209(7):1363-77. PMC: 3405501. DOI: 10.1084/jem.20111343. View

13.

Zhang C, Berndt-Paetz M, Neuhaus J . A Comprehensive Bioinformatics Analysis of Notch Pathways in Bladder Cancer. Cancers (Basel). 2021; 13(12). PMC: 8235546. DOI: 10.3390/cancers13123089. View

14.

Kacer D, McIntire C, Kirov A, Kany E, Roth J, Liaw L . Regulation of non-classical FGF1 release and FGF-dependent cell transformation by CBF1-mediated notch signaling. J Cell Physiol. 2011; 226(11):3064-75. PMC: 3126874. DOI: 10.1002/jcp.22663. View

15.

Chen J, Chang H, Peng X, Gu Y, Yi L, Zhang Q . 3,6-dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway. Sci Rep. 2016; 6:28858. PMC: 4921838. DOI: 10.1038/srep28858. View

16.

Han D, Yu Z, Zhang H, Liu H, Wang B, Qian D . Microenvironment-associated gene HSD11B1 may serve as a prognostic biomarker in clear cell renal cell carcinoma: a study based on TCGA, RT‑qPCR, Western blotting, and immunohistochemistry. Bioengineered. 2021; 12(2):10891-10904. PMC: 8810109. DOI: 10.1080/21655979.2021.1994908. View

17.

Decker J, Hobson E, Zhang Y, Shin S, Thomas A, Jeruss J . Systems analysis of dynamic transcription factor activity identifies targets for treatment in Olaparib resistant cancer cells. Biotechnol Bioeng. 2017; 114(9):2085-2095. PMC: 5522358. DOI: 10.1002/bit.26293. View

18.

Li P, Sun T, Yuan Q, Pan G, Zhang J, Sun D . The expressions of NEDD9 and E-cadherin correlate with metastasis and poor prognosis in triple-negative breast cancer patients. Onco Targets Ther. 2016; 9:5751-5759. PMC: 5036611. DOI: 10.2147/OTT.S113768. View

19.

DeSantis C, Ma J, Gaudet M, Newman L, Miller K, Sauer A . Breast cancer statistics, 2019. CA Cancer J Clin. 2019; 69(6):438-451. DOI: 10.3322/caac.21583. View

20.

Zeng J, Zhang Z, Pei L, Bai Z, Yang Y, Yang H . CBX4 exhibits oncogenic activities in breast cancer via Notch1 signaling. Int J Biochem Cell Biol. 2017; 95:1-8. DOI: 10.1016/j.biocel.2017.12.006. View